| |
| |
|
| Insider
Information: |
Chang Joseph Y |
| Relationship: |
Director |
| City: |
Provo |
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
21,234 |
|
|
Indirect Shares
|
78,068 |
|
|
| Direct
Value |
$264,788 |
|
|
|
Indirect Value
|
$973,508 |
|
|
| Total
Shares |
99,302 |
|
|
| Total
Value |
$1,238,296 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
NU Skin Enterprises Inc |
NUS |
Chief Scientific Officer |
2023-03-02 |
21,234 |
2023-03-02 |
78,068 |
Premium* |
|
|
Optimer Pharmaceuticals Inc |
OPTR |
Director |
2013-10-24 |
0 |
2013-10-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
140 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NUS |
NU Skin Enterprises Inc |
President-Pharmanex Division |
• – – |
2005-09-15 |
4 |
OE |
$8.00 |
$160,000 |
D/D |
20,000 |
22,131 |
|
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2022-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
6,744 |
22,957 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2022-03-01 |
4 |
AS |
$45.21 |
$1,292,213 |
D/D |
(28,577) |
22,957 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2022-03-02 |
4 |
AS |
$45.86 |
$157,597 |
D/D |
(3,423) |
22,957 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2022-06-01 |
4 |
AS |
$46.25 |
$745,058 |
D/D |
(16,000) |
22,957 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2022-12-18 |
4 |
D |
$40.33 |
$263,839 |
D/D |
(6,542) |
23,215 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific OfficerExec V |
• – – |
2020-06-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
13,068 |
24,814 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2022-03-02 |
4 |
OE |
$30.63 |
$104,846 |
D/D |
3,423 |
26,380 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2022-12-18 |
4 |
OE |
$37.58 |
$255,544 |
D/D |
6,800 |
29,757 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific OfficerExec V |
• – – |
2020-09-09 |
4 |
OE |
$39.51 |
$199,091 |
D/D |
5,039 |
29,853 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
EVP, Chief Scientific Officer |
• – – |
2021-09-13 |
4 |
OE |
$30.63 |
$490,080 |
D/D |
16,000 |
33,942 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
President-Pharmanex Division |
• – – |
2004-08-02 |
4 |
OE |
$8.00 |
$280,000 |
D/D |
35,000 |
37,131 |
|
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2020-06-05 |
4 |
S |
$40.01 |
$1,399,150 |
D/D |
(34,970) |
37,882 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2022-06-01 |
4 |
OE |
$30.63 |
$490,080 |
D/D |
16,000 |
38,957 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2016-03-04 |
4 |
S |
$34.21 |
$684,200 |
D/D |
(20,000) |
43,613 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2015-09-02 |
5 |
GA |
$0.00 |
$0 |
I/I |
45,000 |
45,000 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2017-03-02 |
4 |
D |
$50.00 |
$198,600 |
D/D |
(3,972) |
45,266 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2016-02-15 |
4 |
D |
$29.14 |
$54,463 |
D/D |
(1,869) |
45,972 |
0 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
Director |
– • – |
2012-12-24 |
5 |
GD |
$0.00 |
$0 |
I/I |
46,152 |
46,154 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2023-03-02 |
4 |
OE |
$30.45 |
$761,358 |
D/D |
25,000 |
46,234 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2015-11-20 |
5 |
GD |
$0.00 |
$0 |
D/D |
20,000 |
47,841 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2017-03-02 |
4 |
OE |
$28.09 |
$158,006 |
D/D |
5,625 |
49,238 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2017-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
49,766 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2012-03-14 |
4 |
AB |
$59.13 |
$12,890 |
D/D |
218 |
49,984 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2017-06-28 |
4 |
D |
$62.91 |
$118,334 |
D/D |
(1,881) |
51,228 |
0 |
- |
|
140 Records found
|
|
Page 2 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
